Sort
53,477 grants matching “addiction”
Single cell transcriptomic and epigenomic changes during chronic HIV infection and cocaine self-administration
$3,653,101Hongkui Zeng · Allen Institute · U01 · FY2024 · DA
Biomedical Informatics Section (BIS)
$3,652,741Barry J Hoffer · National Institute On Drug Abuse · Z01 · FY2008 · DA
State-dependent Decision-making in Brainwide Neural Circuits
$3,650,051Liam M Paninski · Columbia Univ New York Morningside · U19 · FY2022 · NS
Single cell transcriptomic and epigenomic changes during chronic HIV infection and cocaine self-administration
$3,648,488Hongkui Zeng · Allen Institute · U01 · FY2023 · DA
5/6 HBCD Prenatal Experiences and Longitudinal Development (PRELUDE) Consortium
$3,648,455Weili Lin · Univ Of North Carolina Chapel Hill · U01 · FY2024 · DA
West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE)
$3,632,192Gary O. Rankin · Marshall University · P20 · FY2021 · GM
Evaluating Suvorexant for Sleep Disturbance in Opioid Use Disorder
$3,632,165Andrew S Huhn · Johns Hopkins University · UH3 · FY2021 · DA
State-dependent Decision-making in Brainwide Neural Circuits
$3,627,888Liam M Paninski · Columbia Univ New York Morningside · U19 · FY2023 · NS
Development of PPL-138, a Novel Mixed NOP/Mu Partial Agonist for Treatment of CocaineUse Disorder
$3,623,079Lawrence R Toll · Phoenix Pharmalabs, Inc. · U01 · FY2024 · DA
Greater Southern California Node of the Clinical Trials Network
$3,618,060Yih-Ing Hser · University Of California Los Angeles · UG1 · FY2019 · DA
Development of an MRgFUS system for precision-targeted neuromodulation of pain circuits with simultaneous functional MRI
$3,614,649Charles F Caskey · Vanderbilt University Medical Center · U18 · FY2019 · EB
Integrative genetics of behavior with high throughput technologies
$3,612,191David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2019 · AA
A Methamphetamine Conjugate Vaccine: From Manufacturing to IND
$3,606,802Misty Ward Stevens · Intervexion Therapeutics, Llc · U01 · FY2014 · DA
West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE)
$3,606,689Gary O. Rankin · Marshall University · P20 · FY2022 · GM
Florida Node of The Drug Abuse Clinical Trials Network
$3,605,484Jose Szapocznik · University Of Miami School Of Medicine · U10 · FY2007 · DA
Development of (R,R)-dehydronorketamine for treatment resistant depression
$3,601,077Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2021 · TR
Development of (R,R)-dehydronorketamine for treatment resistant depression
$3,594,882Craig Thomas · National Center For Advancing Translational Sciences · ZIA · FY2019 · TR
Development of SBI-553, an allosteric modulator of NTR1, for the treatment of substance use disorders
$3,588,880Michael Jackson · Sanford Burnham Prebys Medical Discovery Institute · UG3 · FY2019 · DA
West Virginia IDeA Network of Biomedical Research Excellence (WV-INBRE)
$3,582,192Gary O. Rankin · Marshall University · P20 · FY2023 · GM
JCOIN Coordination and Translation Center
$3,567,729Faye S Taxman · George Mason University · U2C · FY2023 · DA
Transspinal Magnetic Stimulation for the Treatment of Neuropathic Pain
$3,565,780Giorgio Bonmassar · Massachusetts General Hospital · R18 · FY2024 · EB
Clinical development of an mGlu2 positive allosteric modulator to treat nicotine addiction
$3,560,198Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · U01 · FY2022 · DA
Tobacco Regulatory Science Investigating the Intersections of Products with Diverse Populations
$3,559,745Mary Ann Pentz · University Of Southern California · U54 · FY2018 · CA
Single cell transcriptomic and epigenomic changes during chronic HIV infection and cocaine self-administration
$3,557,665Hongkui Zeng · Allen Institute · U01 · FY2022 · DA
Translational Methamphetamine AIDS Research Center (TMARC)
$3,557,652Igor Grant · University Of California, San Diego · P50 · FY2017 · DA